Ardent Health, Inc. (NYSE:ARDT) Receives Average Rating of “Hold” from Analysts

Ardent Health, Inc. (NYSE:ARDT) has earned an average rating of “Hold” from the fourteen brokerages that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $12.9545.

ARDT has been the subject of several recent analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a report on Friday, June 12th. Wall Street Zen cut Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $13.00 price objective on shares of Ardent Health in a research report on Thursday. Guggenheim raised their target price on shares of Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Truist Financial raised their target price on shares of Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Thursday.

Insider Activity

In related news, CFO Alfred Lumsdaine acquired 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were acquired at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the acquisition, the chief financial officer directly owned 329,183 shares in the company, valued at approximately $2,900,102.23. The trade was a 3.13% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ARDT. LSV Asset Management bought a new position in shares of Ardent Health during the 4th quarter worth approximately $963,000. Prescott Group Capital Management L.L.C. bought a new stake in shares of Ardent Health in the fourth quarter worth $1,077,000. First Trust Advisors LP boosted its holdings in Ardent Health by 70.9% during the first quarter. First Trust Advisors LP now owns 478,795 shares of the company’s stock worth $4,098,000 after purchasing an additional 198,595 shares during the last quarter. Denali Advisors LLC boosted its holdings in Ardent Health by 35.0% during the fourth quarter. Denali Advisors LLC now owns 249,450 shares of the company’s stock worth $2,203,000 after purchasing an additional 64,650 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its position in Ardent Health by 159.9% in the first quarter. Arrowstreet Capital Limited Partnership now owns 121,374 shares of the company’s stock valued at $1,039,000 after purchasing an additional 74,675 shares in the last quarter.

Ardent Health Trading Up 3.9%

Shares of NYSE ARDT opened at $11.60 on Friday. Ardent Health has a twelve month low of $7.71 and a twelve month high of $15.48. The stock has a market cap of $1.66 billion, a price-to-earnings ratio of 21.09, a P/E/G ratio of 2.62 and a beta of 0.70. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. The company’s fifty day moving average is $9.93 and its 200-day moving average is $9.48.

Ardent Health (NYSE:ARDT) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The firm had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.45%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. Equities research analysts predict that Ardent Health will post 1.06 EPS for the current year.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.